A Three Stage, Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) in Healthy Subjects
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
A Double blinded (oral), Open Label, Study to Assess the Safety, Pharmacokinetics and
Pharmacodynamics of Oral PTH (1-34) in healthy Subjects to establish the safety,
tolerability, bioavailability, pharmacokinetic, and pharmacodynamic profile and the of
Entera's oral PTH(1 - 34) in adult healthy human volunteers.